EP 3821904 A1 20210519 - FORMULA OF NEUREGULIN PREPARATION
Title (en)
FORMULA OF NEUREGULIN PREPARATION
Title (de)
FORMEL ZUR HERSTELLUNG VON NEUREGULIN
Title (fr)
FORMULE DE PRÉPARATION DE LA NEURÉGULINE
Publication
Application
Priority
- CN 201410002665 A 20140103
- EP 14876973 A 20141217
- CN 2014094073 W 20141217
Abstract (en)
The invention relates to a pharmaceutical formulation of neuregulin (NRG) comprising: (a) a NRG polypeptide, and (b) a buffering agent, wherein said formulation has a pH in a range from about 2.0 to about 5.7. The invention further relates to a lyophilized pharmaceutical formulation of NRG, prepared by lyophilization of the pharmaceutical formulation of the invention, wherein an excipient is added into the pharmaceutical formulation prior to the lyophilization.
IPC 8 full level
A61K 38/18 (2006.01); A61P 9/04 (2006.01)
CPC (source: EP KR RU US)
A61K 9/0019 (2013.01 - KR); A61K 9/08 (2013.01 - KR US); A61K 9/1623 (2013.01 - US); A61K 9/19 (2013.01 - KR US); A61K 38/18 (2013.01 - RU); A61K 38/1883 (2013.01 - EP KR US); A61K 47/02 (2013.01 - KR US); A61K 47/12 (2013.01 - RU); A61K 47/26 (2013.01 - KR); A61K 47/42 (2013.01 - RU US); A61P 9/00 (2018.01 - EP KR); A61P 9/04 (2018.01 - EP KR RU)
Citation (applicant)
- WO 0064400 A2 20001102 - CAMBRIDGE NEUROSCIENCE INC [US], et al
- US 5530109 A 19960625 - GOODEARL ANDREW DAVID JOHN [GB], et al
- US 5716930 A 19980210 - GOODEARL ANDREW DAVID JOHN [GB], et al
- WO 9709425 A1 19970313 - HARVARD COLLEGE [US], et al
- US 5834229 A 19981110 - VANDLEN RICHARD L [US], et al
- SAMBROOK ET AL.: "Molecular Cloning", 1989, COLD SPRING HARBOR LABORATORY PRESS, pages: 9.47 - 9.51
- WATSON ET AL.: "Molecular Biology of the Gene", 1987, BENJAMIN CUMMINGS, pages: 224
- HOLMES ET AL., SCIENCE, vol. 256, 1992, pages 1205 - 1210
- HIJAZI ET AL., INT. J. ONCOL., vol. 13, 1998, pages 1061 - 1067
- CARRAWAY ET AL., NATURE, vol. 387, 1997, pages 512 - 516
- HIGASHIYAMA ET AL., J. BIOCHEM., vol. 122, 1997, pages 675 - 680
- TANG ET AL., PHARM RES., vol. 21, 2004, pages 191 - 200
- CHANG ET AL., PHARM RES., vol. 13, 1996, pages 243 - 9
- A. P. MACKENZIE, PHIL TRANS R SOC LONDON, SER B, BIOL, vol. 278, 1977, pages 167
- REMMELE R. L. JR. ET AL., BIOCHEMISTRY, vol. 38, no. 16, 1999, pages 5241 - 7
- LAURSEN T ET AL., BASIC CLIN PHARMACOL TOXICOL., vol. 98, no. 2, 2006, pages 218 - 21
- HOLLANDER-RODRIGUEZ J C ET AL., AM. FAM. PHYSICIAN., vol. 73, no. 2, 2006, pages 283 - 90
- CARPENTER ET AL., DEVELOP. BIOL. STANDARD, vol. 74, 1991, pages 225
- CHEN, DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, vol. 18, 1992, pages 1311 - 1354
Citation (search report)
- [A] WO 2009033373 A1 20090319 - ZENSUN SHANGHAI SCIENCE & TECH [CN], et al
- [A] WO 2010060266 A1 20100603 - ZENSUN SHANGHAI SCIENCE & TECH [CN], et al
- [A] WO 2007076701 A1 20070712 - ZENSUN SHANGHAI SCIENCE & TECH [CN], et al
- [E] EP 2903632 A1 20150812 - ZENSUN SHANGHAI SCIENCE AND TECHNOLOGY LTD [CN]
- [E] EP 2964249 A1 20160113 - ACORDA THERAPEUTICS INC [US]
- [A] WO 02095122 A1 20021128 - BASF AG [DE], et al
- [A] EP 1876227 A1 20080109 - PROCTER & GAMBLE [US]
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 3090756 A1 20161109; EP 3090756 A4 20170719; EP 3090756 B1 20200930; AU 2014375637 A1 20160714; BR 112016015660 A2 20171024; CA 2935607 A1 20150709; CN 104758922 A 20150708; CN 105960248 A 20160921; CN 110946993 A 20200403; CN 111012898 A 20200417; EP 3821904 A1 20210519; JP 2017502969 A 20170126; JP 2020143101 A 20200910; JP 2022130627 A 20220906; JP 6703483 B2 20200603; JP 7100083 B2 20220712; JP 7479068 B2 20240508; KR 102522140 B1 20230417; KR 20160105443 A 20160906; KR 20220093387 A 20220705; KR 20230054749 A 20230425; RU 2016131667 A 20180208; RU 2016131667 A3 20180821; RU 2738158 C2 20201208; US 10702585 B2 20200707; US 11969458 B2 20240430; US 2017007671 A1 20170112; US 2021113661 A1 20210422; WO 2015101182 A1 20150709
DOCDB simple family (application)
EP 14876973 A 20141217; AU 2014375637 A 20141217; BR 112016015660 A 20141217; CA 2935607 A 20141217; CN 2014094073 W 20141217; CN 201410002665 A 20140103; CN 201480071227 A 20141217; CN 201911388095 A 20140103; CN 201911390381 A 20141217; EP 20195273 A 20141217; JP 2016544419 A 20141217; JP 2020082456 A 20200508; JP 2022105452 A 20220630; KR 20167020428 A 20141217; KR 20227021093 A 20141217; KR 20237012378 A 20141217; RU 2016131667 A 20141217; US 201415109583 A 20141217; US 202016894540 A 20200605